Predict your next investment

University of Strathclyde company logo
Academic/University
CONSUMER PRODUCTS & SERVICES | Education & Training (non-internet/mobile) / Colleges & Universities
strath.ac.uk

See what CB Insights has to offer

Investments

16

Portfolio Exits

1

Funds

1

Partners & Customers

10

About University of Strathclyde

University of Strathclyde is an international technological University located in the heart of Glasgow, Scotland's biggest city. Its commitment to useful learning guides its research, learning and teaching and the way it works with businesses and organizations.

University of Strathclyde Headquarter Location

16 Richmond Street

Glasgow, Scotland, G1 1XQ,

United Kingdom

+44 141 552 4400

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing University of Strathclyde

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find University of Strathclyde in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

University of Strathclyde Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

University of Strathclyde Rank

Latest University of Strathclyde News

Rapid discovery: Diagnosing cancers quickly

Sep 22, 2021

Rapid discovery: Diagnosing cancers quickly × The company, previously named Clinspec Diagnostics Ltd, is a spin-out from the University of Strathclyde. Dr Baker is the inventor of the technology. After he took up a lectureship at Strathclyde he was able to use the entrepreneurial university ecosystem and the business acumen of Dr Hegarty to develop his innovation, based around a test for brain cancer, into a business. Explaining the recent rebrand, Dr Hegarty alluded to theme of discovery, which is evident in the company’s new name. “DX is a shorthand for diagnostics. ‘Dxcover Brain Cancer’ as a test for brain cancer was a great theme for us to start developing. The rebranding was all about us taking this next step. We raised funding that spun us out from the university as a company, in February 2019, and then we raised our second round of funding which was completed in February this year." This comes at a time when, as Hegarty puts it, people have become more “switched on” to testing, particularly bloods and biofluids, and the COVID-19 pandemic has accelerated this change given the need for rapid diagnostics. Though perceptions around testing may have changed, as well as the confidence of the public to test for conditions, cancer diagnostics is still the fastest growing market in the diagnostics space. Dr Baker said: “Leaving COVID aside, it’s the fastest growing and still will be the fastest growing market. Post-COVID, waiting times have massively increased, so there is a requirement for more diagnostic testing for cancer and better testing methods to detect cancer earlier.” According to Cancer Research UK, 12,000 people in Britain are diagnosed with brain tumours every year and survival rates are as low as 12% five years after diagnosis. When Baker started the project, it was targeting difficult-to-diagnose tumours, notably brain and pancreatic tumours, with the aim of increasing survival rates. Explaining the rationale behind Dxcover’s business, Hegarty pointed to the higher incidence of cancer and its increasing prevalence among an ageing population– with a 43% increase in diagnostics rates expected for the disease over the next 20 years. As for Dxcover’s technology, Baker explains it is based upon infrared spectroscopy – enabling rapid testing of human blood. A blood sample is taken, extracted into serum followed by the “drop, dry, detect,” technique by pipetting human serum onto a silicon slide, which is then dried and analysed. Baker added: “We don’t have to isolate any genetic markers, we don’t have to sequence any material, we don’t have to any multi-step sample preparation. We have a very rapid automated platform technology that we can use for analysis. “We don’t just focus on a single information source. If you imagine your blood serum, it’s got lots of different constituent parts including DNA material, proteins, carbohydrates, and electrolytes. Scientists behind other liquid biopsies would say “I am really interested in protein A or protein B, or genetic sequence X or genetic sequence Y,” and they would go and look for these markers. What we do is say ‘what is there?’ not ‘is this there?’ “We essentially analyse the entire molecular complement of blood serum and then use machine learning to tease it apart, which provides us with a unique signature. We use infrared spectroscopy because it is an excellent global analysis technique to which we then apply artificial intelligence and machine learning.” The company has already successfully completed two clinical studies on detection of brain cancer and recently published a third. In its latest study of 177 patients, published this Summer in the peer-reviewed Cancers journal, the results showed that Dxcover’s testing technology, the Dxcover Liquid Biopsy, is effective even in the earlier days of cancer growth, at a smaller volume and lower stage. Earlier detection, when a tumour is smaller, reduces the harm from surgery and other treatments, so people can live better, for longer. By detecting extremely small tumours, the research provides the evidence that Dxcover's diagnostic test can have a significant impact in shortening the time from symptom onset to diagnosis for patients, supporting primary care doctors in their decision making.

University of Strathclyde Investments

16 Investments

University of Strathclyde has made 16 investments. Their latest investment was in R3-IoT as part of their Seed VC on July 7, 2021.

CBI Logo

University of Strathclyde Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/27/2021

Seed VC

R3-IoT

$4.3M

Yes

Loren Padelford, Nathan Kundtz, Ryan Johnson, Scottish Enterprise, Scottish National Investment Bank, and Space Capital

5

3/4/2021

Series A - II

Dxcover

$1.54M

No

EOS Advisory, and Norcliffe Capital

1

9/7/2020

Series A

Dxcover

$3.13M

Yes

EOS Advisory, Mercia Asset Management, Scottish Investment Bank, and SIS Ventures

4

5/13/2019

Series A

Subscribe to see more

$99M

Subscribe to see more

10

4/4/2018

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/27/2021

3/4/2021

9/7/2020

5/13/2019

4/4/2018

Round

Seed VC

Series A - II

Series A

Series A

Series A

Company

R3-IoT

Dxcover

Dxcover

Subscribe to see more

Subscribe to see more

Amount

$4.3M

$1.54M

$3.13M

$99M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Loren Padelford, Nathan Kundtz, Ryan Johnson, Scottish Enterprise, Scottish National Investment Bank, and Space Capital

EOS Advisory, and Norcliffe Capital

EOS Advisory, Mercia Asset Management, Scottish Investment Bank, and SIS Ventures

Sources

5

1

4

10

10

University of Strathclyde Portfolio Exits

1 Portfolio Exit

University of Strathclyde has 1 portfolio exit. Their latest portfolio exit was Sivers Photonics on May 02, 2017.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

5/2/2017

Acquired

1

Date

5/2/2017

Exit

Acquired

Companies

Valuation

Acquirer

Sources

1

University of Strathclyde Acquisitions

1 Acquisition

University of Strathclyde acquired 1 company. Their latest acquisition was Dxcover on January 01, 2016.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

1/1/2016

Series A

$6.23M

Spinoff / Spinout

Date

1/1/2016

Investment Stage

Series A

Companies

Valuation

Total Funding

$6.23M

Note

Spinoff / Spinout

Sources

University of Strathclyde Fund History

1 Fund History

University of Strathclyde has 1 fund, including Strathclyde Entrepreneurs Fund.

Closing Date

Fund

Fund Type

Status

Amount

Sources

Strathclyde Entrepreneurs Fund

1

Closing Date

Fund

Strathclyde Entrepreneurs Fund

Fund Type

Status

Amount

Sources

1

University of Strathclyde Partners & Customers

10 Partners and customers

University of Strathclyde has 10 strategic partners and customers. University of Strathclyde recently partnered with Wood on July 7, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

7/19/2021

Partner

Wood

United Kingdom

Wood, AIG and the University of Strathclyde partner to create a more resilient world

The partnership between Wood , AIG and the University of Strathclyde under the United Nations SDG 17 will see the three organisations work together to create a roadmap around building more sustainable infrastructure and driving down carbon emissions .

2

7/19/2021

Partner

Wood

United Kingdom

University of Strathclyde, AIG and Wood partner to help create net zero cities

`` Our partnership with AIG and the University of Strathclyde demonstrates the power of collaborating across multiple sectors and with a broad range of stakeholders to drive sustainable and resilient solutions . ''

1

3/25/2021

Partner

Eni

Italy

Eni and the University of Strathclyde together to support transition of workforces to the renewable energy sector

Alessandro Della Zoppa , Director of Eni , said : `` We are delighted to partner with the prestigious University of Strathclyde to develop a ground-breaking programme that intends to inspire the industry and create a model to replicate in the UK and internationally .

1

3/12/2021

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

3/11/2021

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

7/19/2021

7/19/2021

3/25/2021

3/12/2021

3/11/2021

Type

Partner

Partner

Partner

Partner

Partner

Business Partner

Wood

Wood

Eni

Country

United Kingdom

United Kingdom

Italy

Subscribe to see more

Subscribe to see more

News Snippet

Wood, AIG and the University of Strathclyde partner to create a more resilient world

The partnership between Wood , AIG and the University of Strathclyde under the United Nations SDG 17 will see the three organisations work together to create a roadmap around building more sustainable infrastructure and driving down carbon emissions .

University of Strathclyde, AIG and Wood partner to help create net zero cities

`` Our partnership with AIG and the University of Strathclyde demonstrates the power of collaborating across multiple sectors and with a broad range of stakeholders to drive sustainable and resilient solutions . ''

Eni and the University of Strathclyde together to support transition of workforces to the renewable energy sector

Alessandro Della Zoppa , Director of Eni , said : `` We are delighted to partner with the prestigious University of Strathclyde to develop a ground-breaking programme that intends to inspire the industry and create a model to replicate in the UK and internationally .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

1

1

10

10

University of Strathclyde Team

2 Team Members

University of Strathclyde has 2 team members, including current Chief Executive Officer, Fiona Strens.

Name

Work History

Title

Status

Fiona Strens

UK Ministry of Defence

Chief Executive Officer

Current

Adrian Gillespie

Scottish Enterprise, and Marks & Spencer

Chief Commercial Officer

Current

Name

Fiona Strens

Adrian Gillespie

Work History

UK Ministry of Defence

Scottish Enterprise, and Marks & Spencer

Title

Chief Executive Officer

Chief Commercial Officer

Status

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.